361 related articles for article (PubMed ID: 9436464)
1. Synergy between CD28 and CD9 costimulation for naive T-cell activation.
Toyo-oka K; Tai XG; Yashiro Y; Ahn HJ; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
Immunol Lett; 1997 Jun; 58(1):19-23. PubMed ID: 9436464
[TBL] [Abstract][Full Text] [Related]
2. A role for CD9 molecules in T cell activation.
Tai XG; Yashiro Y; Abe R; Toyooka K; Wood CR; Morris J; Long A; Ono S; Kobayashi M; Hamaoka T; Neben S; Fujiwara H
J Exp Med; 1996 Aug; 184(2):753-8. PubMed ID: 8760830
[TBL] [Abstract][Full Text] [Related]
3. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis.
Tai XG; Toyooka K; Yashiro Y; Abe R; Park CS; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
J Immunol; 1997 Oct; 159(8):3799-807. PubMed ID: 9378967
[TBL] [Abstract][Full Text] [Related]
4. A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other co-stimulatory molecules.
Yashiro Y; Tai XG; Toyo-oka K; Park CS; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
Eur J Immunol; 1998 Mar; 28(3):926-35. PubMed ID: 9541588
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
6. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
Gimmi CD; Freeman GJ; Gribben JG; Sugita K; Freedman AS; Morimoto C; Nadler LM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6575-9. PubMed ID: 1650475
[TBL] [Abstract][Full Text] [Related]
7. CD43 is a murine T cell costimulatory receptor that functions independently of CD28.
Sperling AI; Green JM; Mosley RL; Smith PL; DiPaolo RJ; Klein JR; Bluestone JA; Thompson CB
J Exp Med; 1995 Jul; 182(1):139-46. PubMed ID: 7790813
[TBL] [Abstract][Full Text] [Related]
8. Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated, naive T cells and TCR-restimulated, activated T cells.
Park CS; Yashiro Y; Tai XG; Toyo-oka K; Hamaoka T; Yagita H; Okumura K; Neben S; Fujiwara H
J Immunol; 1998 Jun; 160(12):5790-6. PubMed ID: 9637489
[TBL] [Abstract][Full Text] [Related]
9. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts.
Yashiro-Ohtani Y; Zhou XY; Toyo-Oka K; Tai XG; Park CS; Hamaoka T; Abe R; Miyake K; Fujiwara H
J Immunol; 2000 Feb; 164(3):1251-9. PubMed ID: 10640738
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.
Osorio LM; Rottenberg M; Jondal M; Chow SC
Immunology; 1998 Mar; 93(3):358-65. PubMed ID: 9640246
[TBL] [Abstract][Full Text] [Related]
11. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway.
Reinhold MI; Lindberg FP; Kersh GJ; Allen PM; Brown EJ
J Exp Med; 1997 Jan; 185(1):1-11. PubMed ID: 8996237
[TBL] [Abstract][Full Text] [Related]
12. Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies.
Harada M; Okamoto T; Omoto K; Tamada K; Takenoyama M; Hirashima C; Ito O; Kimura G; Nomoto K
Immunology; 1996 Mar; 87(3):447-53. PubMed ID: 8778032
[TBL] [Abstract][Full Text] [Related]
13. CD28 costimulation induces delta opioid receptor expression during anti-CD3 activation of T cells.
Nguyen K; Miller BC
J Immunol; 2002 May; 168(9):4440-5. PubMed ID: 11970987
[TBL] [Abstract][Full Text] [Related]
14. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
Giese T; Allison JP; Davidson WF
J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
[TBL] [Abstract][Full Text] [Related]
15. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
16. CD81 and CD28 costimulate T cells through distinct pathways.
Witherden DA; Boismenu R; Havran WL
J Immunol; 2000 Aug; 165(4):1902-9. PubMed ID: 10925271
[TBL] [Abstract][Full Text] [Related]
17. CD28 is not required for c-Jun N-terminal kinase activation in T cells.
Rivas FV; O'Herrin S; Gajewski TF
J Immunol; 2001 Sep; 167(6):3123-8. PubMed ID: 11544297
[TBL] [Abstract][Full Text] [Related]
18. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
19. Role of mRNA stability in the different patterns of cytokine production by CD4+ cells from young and old mice.
Pioli C; Pucci S; Barile S; Frasca D; Doria G
Immunology; 1998 Jul; 94(3):380-7. PubMed ID: 9767421
[TBL] [Abstract][Full Text] [Related]
20. Use of the methylxanthine derivative A802715 in transplantation immunology: I. Strong in vitro inhibitory effects on CD28-costimulated T cell activities.
Lin Y; Goebels J; Rutgeerts O; Kasran A; Van Gool S; Ceuppens J; Schönharting M; Waer M
Transplantation; 1997 Jun; 63(12):1813-8. PubMed ID: 9210510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
